Logo image of VPI.CA

VITALITY PRODUCTS INC (VPI.CA) Stock Fundamental Analysis

TSX-V:VPI - TSX Venture Exchange - CA92847D1050 - Common Stock - Currency: CAD

0.03  0 (0%)

Fundamental Rating

1

Overall VPI gets a fundamental rating of 1 out of 10. We evaluated VPI against 4 industry peers in the Personal Care Products industry. Both the profitability and financial health of VPI have multiple concerns. VPI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VPI had negative earnings in the past year.
In the past year VPI has reported a negative cash flow from operations.
VPI had negative earnings in each of the past 5 years.
VPI had a negative operating cash flow in each of the past 5 years.
VPI.CA Yearly Net Income VS EBIT VS OCF VS FCFVPI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

1.2 Ratios

With a Return On Assets value of -23.60%, VPI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -23.6%
ROE N/A
ROIC N/A
ROA(3y)-38.32%
ROA(5y)-27.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VPI.CA Yearly ROA, ROE, ROICVPI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

VPI has a better Gross Margin (72.30%) than 100.00% of its industry peers.
VPI's Gross Margin has been stable in the last couple of years.
VPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y0.07%
VPI.CA Yearly Profit, Operating, Gross MarginsVPI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

VPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
VPI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, VPI has more shares outstanding
VPI has a better debt/assets ratio than last year.
VPI.CA Yearly Shares OutstandingVPI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VPI.CA Yearly Total Debt VS Total AssetsVPI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

VPI has an Altman-Z score of -30.28. This is a bad value and indicates that VPI is not financially healthy and even has some risk of bankruptcy.
VPI has a Altman-Z score (-30.28) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.28
ROIC/WACCN/A
WACC7.56%
VPI.CA Yearly LT Debt VS Equity VS FCFVPI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M

2.3 Liquidity

A Current Ratio of 0.21 indicates that VPI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.21, VPI is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 0.16 indicates that VPI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.16, VPI is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.16
VPI.CA Yearly Current Assets VS Current LiabilitesVPI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.49% over the past year.
Looking at the last year, VPI shows a decrease in Revenue. The Revenue has decreased by -5.91% in the last year.
Measured over the past years, VPI shows a quite strong growth in Revenue. The Revenue has been growing by 8.32% on average per year.
EPS 1Y (TTM)53.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-5.91%
Revenue growth 3Y-1.67%
Revenue growth 5Y8.32%
Sales Q2Q%-16.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VPI.CA Yearly Revenue VS EstimatesVPI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
VPI.CA Price Earnings VS Forward Price EarningsVPI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VPI.CA Per share dataVPI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VPI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VITALITY PRODUCTS INC

TSX-V:VPI (6/4/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-28 2025-05-28
Earnings (Next)06-25 2025-06-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners20.45%
Ins Owner ChangeN/A
Market Cap1.24M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.7
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.02
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.3%
FCFM N/A
ROA(3y)-38.32%
ROA(5y)-27.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y0.07%
F-Score4
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.16
Altman-Z -30.28
F-Score4
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)52.06%
Cap/Depr(5y)40.57%
Cap/Sales(3y)0.58%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.91%
Revenue growth 3Y-1.67%
Revenue growth 5Y8.32%
Sales Q2Q%-16.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.18%
OCF growth 3YN/A
OCF growth 5YN/A